19 December 2022
Osirium Technologies plc
("Osirium" or the "Company")
Holdings in Company
Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, has been notified that, following a purchase of ordinary shares of 1p each in the Company ("Ordinary Shares") earlier today, Nicholas Slater's interest in the Company's shares now totals 13,550,000 Ordinary Shares, representing 11.06 per cent. of the Company's issued share capital.
| Contacts: | |
| | |
| Osirium Technologies plc | Tel: +44 (0)1183 242 444 |
| David Guyatt, CEO | |
| Rupert Hutton, CFO | |
| | |
| Allenby Capital Limited (Nominated adviser and broker) | Tel: +44 (0)20 3328 5656 |
| James Reeve / George Payne (Corporate Finance) | |
| Tony Quirke (Sales and Corporate Broking) | |
| | |
| Alma PR (Financial PR adviser) | Tel: +44 (0)20 3405 0205 |
| Hilary Buchanan | osirium@almapr.co.uk |
| Kieran Breheny | |
| Will Ellis Hancock | |
About Osirium Technologies Plc
Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.
With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.
Founded in 2008 and with its headquarters in Reading, UK, the Company's shares were admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.